Search

everythinglearnresearchcommunity

for

Search:↓

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

A genetic marker linked to a type of hair loss was found in most patients studied.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Two mouse mutations cause similar hair loss despite different skin changes.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Deleting the p63 gene in certain cells causes problems in thymus development and severe hair loss in mice.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

The study suggests silicon might be important for healthy hair, as less silicon was found in people with hair loss.

A rare combination of halo nevi, nonsegmental vitiligo, and early gray hair can occur together.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The document says that there are treatments for hair and nail diseases.

Scientists made a mouse that can be made to lose hair and then grow it back.

miR-29 is a key factor that accelerates aging.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.